Sign in
8-K

Current Report

Evofem Biosciences, Inc. Filed Acc 0001564590-17-013320

Exit or restructuring costs · Executive or director change · Other events

  • Item 2.05 Costs associated with exit or disposal activities
  • Item 5.02 Departure or appointment of directors or officers
  • Item 8.01 Other events

From the SEC's structured data for this filing

Loading neot-8k_20170710.htm…